Veozah availability in 2026: What you need to know

If you take Veozah (Fezolinetant) for moderate to severe menopause hot flashes, here's what you need to know about availability, pricing, and your options in 2026.

The short version: Veozah is not on the FDA drug shortage list, but that doesn't mean every pharmacy has it. Many patients still report difficulty finding it in stock at their local pharmacy. Here's the full picture.

Is Veozah still in shortage in 2026?

No — Veozah is not listed on the FDA drug shortage database as of March 2026 and has never been officially listed as in shortage. However, "not in shortage" and "easy to find" are two very different things.

Veozah is a brand-only medication from a single manufacturer (Astellas Pharma) with a cash price of $550–$765 per month. These factors mean many pharmacies don't stock it routinely. The result is what pharmacists call localized unavailability — the drug exists in the supply chain, but it's not sitting on every pharmacy's shelf waiting for you.

Why is Veozah still hard to find at some pharmacies?

Several factors contribute to ongoing availability challenges:

Wholesaler allocation limits

Pharmaceutical wholesalers — the companies that supply medications to pharmacies — often limit how much of a given product each pharmacy can order. For newer, expensive brand-name drugs like Veozah, these limits can be tighter, making it harder for pharmacies to maintain consistent stock.

Pharmacy stocking economics

A 30-day supply of Veozah costs $550–$765 at retail. That's a significant inventory investment for a pharmacy, especially if they only have a few patients filling it regularly. Many pharmacies — particularly chains — only order Veozah when a patient actively requests it, rather than keeping it on the shelf.

Demand is growing

As awareness of nonhormonal options for menopause hot flashes has grown, more women are asking their doctors about Veozah. The FDA approval of Lynkuet (elinzanetant) in late 2025 has also drawn attention to this drug class overall, potentially increasing interest in Veozah as well. Growing demand can create temporary local shortages.

Insurance delays

Prior authorization requirements mean there's often a lag between when a prescription is written and when a patient shows up to fill it. This unpredictability makes it harder for pharmacies to forecast demand.

How much does Veozah cost in 2026?

Without insurance

The cash price for a 30-day supply (30 tablets of 45 mg) is typically $550–$765, depending on the pharmacy. Discount card programs may bring this down somewhat:

• SingleCare: as low as ~$573
• GoodRx: prices vary by location, typically $550–$700

With insurance

Many commercial insurance plans cover Veozah, but coverage varies widely:

• Often placed on Tier 3 (preferred brand) or Tier 4 (non-preferred brand)
• Prior authorization is commonly required
• Some plans require step therapy — you may need to try Brisdelle or HRT first
• Copays typically range from $30–$150 per month depending on your plan

Savings programs

Astellas offers the VEOZAH Savings Card for patients with commercial insurance:

• Pay as little as $0 for the first month
• As little as $30 per monthly refill
• Up to $4,000 in copay assistance per year
• Enroll at veozah.com/savings

For uninsured patients, Astellas offers patient assistance through VEOZAH Support Solutions at veozahsupportsolutions.com. Additional help may be available through NeedyMeds and RxAssist.

For a complete breakdown, see our guide on how to save money on Veozah in 2026.

New options in 2026

The menopause treatment landscape has expanded since Veozah launched in 2023:

• Lynkuet (Elinzanetant): FDA approved in October 2025, this Bayer medication is a dual NK1/NK3 receptor antagonist. It works similarly to Veozah but also targets the NK1 receptor, which may help with sleep problems. It became available in the U.S. in November 2025.
• Expanded HRT options: New formulations and delivery methods for hormone replacement therapy continue to reach the market, giving women more ways to manage menopause symptoms.

For a full comparison, see our guide on alternatives to Veozah.

How to find Veozah in stock near you in 2026

Here are the most effective steps to find Veozah:

1. Use Medfinder — the fastest way to check which pharmacies near you have Veozah in stock, without calling around yourself
2. Try independent pharmacies — they often have more flexibility in ordering specialty medications and may work with different wholesalers than chains
3. Plan ahead — contact your pharmacy at least one week before you need a refill so they can order it if needed
4. Ask about specific doses — Veozah only comes in one dose (45 mg), but confirming this with the pharmacy avoids confusion

Final thoughts

Here are the key takeaways for Veozah patients in 2026:

1. Veozah is not on the FDA shortage list, but localized availability issues persist
2. Cash price remains high at $550–$765/month, but the Astellas Savings Card can reduce costs to as low as $30/month
3. A new nonhormonal alternative — Lynkuet (Elinzanetant) — is now available
4. Medfinder is the best tool for finding Veozah in stock without calling pharmacies

For more help, read our guides on how to find Veozah in stock near you, what is Veozah, and Veozah side effects.